UK Smoking Rates at Historic Low as E-Cigarette Use Increases

Dec.07.2022
UK Smoking Rates at Historic Low as E-Cigarette Use Increases
Smoking in the UK hit an all-time low in 2021, but more people are turning to e-cigarettes, according to data.

New data shows that the number of smokers in the UK reached a historic low last year, but more people are using e-cigarettes.


According to data from the UK's National Statistics Office, approximately 13.3% of people aged 18 or older smoked in 2021, which is lower than the 14.0% reported in 2020.


However, among people aged 16 and above, 7.7% of them reported using e-cigarettes, compared to 6.4% in 2020.


The first record from the UK National Statistics Office about smoking was in 2011, which found that 20.2% of people had smoked at some point.


The UK's National Statistics Office has stated that the latest data represents a "statistically significant" decrease.


Is vaping a risk-free choice? Should disposable e-cigarettes be banned? James Tucker, who works in data analysis for the UK's Office for National Statistics' social care and health department, suggests that the decrease in smokers may partly be due to more people turning to e-cigarettes.


He said, "This is the lowest current smoking rate since 2011, when we began documenting smoking rates through the annual Population Survey (APS).


According to the UK's National Statistics Office, electronic cigarettes and other vaping devices have played a "significant role" in reducing the number of smokers in the UK.


According to the report, the use of electronic cigarettes is highest among current smokers, at 25.3%, followed by former smokers at 15.0%. Only 1.5% of those who have never smoked reported using e-cigarettes.


However, it added that electronic cigarettes may not be the only factor contributing to the decline in smoking. (Translated from Chinese)


This may also be due to increased public awareness campaigns and the implementation of smoke-free policies in places such as bars and offices.


The government's tobacco control program aims to reduce smoking rates among adults in England to 12% or lower by the end of 2022.


According to the UK's National Statistics Office, Scotland currently has the highest proportion of smokers in the country for 2021 at 14.8%, while England has the lowest at 13.0%.


In other locations, Wales and Northern Ireland have reported respective current smoking rates of 14.1% and 13.8%.


By 2021, men are more likely to be current smokers in the UK with a smoking rate of 15.1% compared to women's rate of 11.5%.


Currently, the age group with the most smokers is 25 to 34 years old, accounting for 15.8%, while the lowest is people aged 65 and over, at 8%.


According to the UK's Office for National Statistics, those who are not qualified are currently more likely to smoke, at a rate of 28.2%, compared to those with a degree or equivalent educational qualifications, who have a smoking rate of 6.6%.


According to the NHS website, while electronic cigarettes are not without some risk, that risk is lower than that of traditional cigarettes. However, the long-term effects of using electronic cigarettes have yet to be fully understood.


Selling e-cigarettes to those under the age of 18 is illegal.


2FIRSTS will continue to report on this topic and provide updates on our mobile app, 2FIRSTSAPP. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
InterTabac 2026 opened in Dortmund, Germany, on September 15 alongside NUBIZ and InterSupply. According to the latest figures released by the organizer, the three trade shows bring together around 750 exhibitors from 64 countries. On site, 2Firsts observed vaping and related brands including VAPORESSO, DOJO, SKE, GREENTANK, GEEK BAR, HQD and ELUX.
Special Report
Sep.15
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24